Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: Applications to highly cited trials in cardiovascular medicine

Circulation

Volumn 99, Issue 3, 1999, Pages 377-383

  Mancini, G B John ^a,b   Schulzer, Michael ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cardiovascular diseases; Clinical trials; Number needed to harm; Number needed to treat; Unqualified success unmitigated failure

Indexed keywords

ARTICLE; HEALTH CARE DELIVERY; HEALTH SERVICE; HEART ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032890561     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.3.377     Document Type: Article

References (22)

1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318: 1728-1733.
2. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Deciding on the best therapy. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, Mass: Little, Brown and Co; 1991:205-209.
3. Schulzer M, Mancini GBJ. "Unqualified success" and "unmitigated failure": number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events, Int J Epidemiol. 1996;25:704-712.
4. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med. 1997;126:712-720.
5. Hull JC, Moore PG, Thomas H. Utility and its measurement. J Roy Stat Soc. Series A. 1973;36:226-247.
6. Connelly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol. 1991;18:349-355.
7. Persson U, Silverberg R, Lindgren B, Norrving B, Jadback G, Johansson B, Puranen BI. Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care. 1990;6:125-137.
8. Asplund K, Marke L-A, Terent A, Gustafsson C, Wester PO. Costs and gains in stroke prevention: European perspective. Cerebrovasc Dis. 1993; 3(suppl 1):34-42.
9. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardio-version: a meta-analysis of randomized control trials. Circulation. 1990; 82:1106-1116.
10. Lee MA, Morady F, Kadish A, Schamp DJ, Chin MC, Scheinman MM, Griffin JC, Lesh MD, Pederson D, Goldberger J, Calkins H, de Buitleir M, Kou WH, Rosenheck S, Sousa J, Langberg JJ. Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia. Circulation. 1991;83: 827-835.
11. Calkins G, Sousa J, El-Atassi R, Rosenheck S, de Buitleir M, Kou WH, Kadish AH, Langberg J, Morady F. Diagnosis and cure of the Wolff-Parkinson-White Syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. 1991;324: 1612-1618.
12. Jackman WM, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, Margolis PD, Calame JD, Overholt ED, Lazzara R. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White Syndrome) by radio-frequency current. N Engl J Med. 1991;324:1605-1611.
13. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
14. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheiner JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
15. Cohn JN, John G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325: 3303-3310.
16. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet. 1990;336:65-71.
17. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Sawin HS, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC, and the POSCH Group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med. 1990; 323:946-955.
18. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Heeker H, Jost S, Deckers JW. Retardation of angiographie progression of coronary artery disease by nifedipine: results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet. 1990;335:1109-1113.
19. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Int Med. 1992;117:916-921.
20. Bobbio M, Demichelis B, Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet. 1994;343: 1209-1211.
21. Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analyses of randomized trials. J Clin Epidemiol. 1994;47:881-889.
22. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ. 1995;311:1056-1060.